Oct 21, 2019 - J&J (JNJ) voluntarily recalls one lot of its baby powders, which is the subject of numerous lawsuits claiming that its talc-based products contain asbestos that causes cancer.
Oct 17, 2019 - Gabelli & Co issues rating change for TEVA
Oct 16, 2019 - Three major drug distributors – McKesson, AmerisourceBergen and Cardinal Health – are in discussions to pay $18 billion, while drugmaker Johnson & Johnson has offered $4 billion.
Oct 15, 2019 - J&J (JNJ) comes up with encouraging third-quarter 2019 results.
Oct 14, 2019 - Eli Lilly (LLY) gets FDA approval for lasmiditan oral tablets to treat acute migraine in adults.
Oct 12, 2019 -
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't like Teva Pharmaceutical Industries Ltd (NYSE: TEVA). He would sell the stock.
Oct 11, 2019 - Jim Cramer takes calls and opines on viewer stock picks of the day in rapid speed.
Oct 10, 2019 - Advancing its turnaround plan that includes the divestment of a range of assets, Teva Pharmaceutical Industries (TEVA +1.5%) has agreed to sell its Shoham-based 50,000 sq. ft. logistics center to real
Oct 07, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $6.98 in the latest trading session, marking a +0.14% move from the prior day.
Oct 07, 2019 - The FDA approval of the self-administration option and auto-injector of AstraZeneca's (AZN) Fasenra is supported by data from the phase III GRECO study and the phase I AMES study